1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Distribution
MakingORG, Inc.

MakingORG, Inc.

CQCQ
MakingORG, Inc.US flagOther OTC
0.75
USD
- -
- -
26.66MMarket Cap
MakingORG, Inc.
CQCQ
(Other OTC)

Recent

price

0.75

P/E

ratio

- -

div

yld

- -

ROIC.AI

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
0.01
0.01
0.02
- -
- -
Revenue per Share
- -
- -
- -
- -
- -
- -
-0.01
-0.01
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
-0.01
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
-0.01
-0.01
-0.03
-0.03
-0.03
- -
-0.04
Book Value per Share
- -
- -
- -
- -
- -
-0.01
-0.01
-0.01
-0.02
-0.02
- -
-0.02
Tangible Book Value per Share
- -
35
35
35
35
35
35
36
36
36
- -
36
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
Sales/Revenue/Turnover
- -
-905.9
- -
- -
- -
-179.24
- -
-115.71
-40.69
3.87
-242.51
-40.04
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
-1
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
160.61
- -
- -
Effective Tax Rate (%)
- -
-905.9
- -
- -
- -
-269.04
- -
-137.83
-69.51
-0.1
-300.26
-61.64
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
-1
-1
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
-17.41
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
3
- -
-1.34
Return on Capital (%)
- -
-162.87
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'23
Jun'23
Sep'23
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
36
36
36
Market Capitalization
27
27
- -

Working Capital

FRC

•

in mil. unless spec.
Mar'23
Jun'23
Sep'23
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.05%
27.68%
23.76%
Free Cash Flow
- -
-15.61%
-371.99%
Net Income, GAAP
- -
3,776%
18,850.33%
Sales/Revenue/Turnover
- -
- -
-93.66%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
1
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
Sinopharm Group Co. Ltd. (SHTDF)
Winnergy Medical Public Company Limited (WINMED.BK)
Bijoy Hans Ltd. (BIJHANS.BO)
McKesson Corporation (MCK)
Charmacy Pharmaceutical Co., Ltd. (2289.HK)
MediPal Holdings Corporation (7459.T)
Business
MakingORG, Inc. (CQCQ) purchases and sells Acer truncatum bunge seed oil in the People's Republic of China, outsourcing production of related health products including nervonic acid oil, coffee, and tea to third parties for distribution to end users and intermediaries in China and the United States; the company operates in the food processing and health products segment with sales concentrated in the PRC. Wholly owned subsidiaries include HK Feng Wang Group Limited and Chongqing Beauty Kenner Biotechnology Co., Ltd. Founded in 2012 and formerly known as Drimex Inc., which changed its name in August 2014, MakingORG maintains headquarters in Walnut, California, with prior references to Chongqing, China, and recent listings in City of Industry, California. The company reports minimal employees at two and focuses operations through its Chinese subsidiaries for sourcing and outsourcing. No major partnerships, acquisitions, funding rounds, or new product launches appear in recent public records for 2024-2025.